Amble vs Arc-1
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amble
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
Arc-1
Best for patients seeking per-dose compounded GLP-1 without subscriptionsStarting at $250/mo
Side-by-Side Comparison
| Feature | Amble | Arc-1 |
|---|---|---|
| Overall Score | ✓7.4/10 | 6.4/10 |
| Starting Price | ✓$179/mo | $250/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.2 ★ /5 |
| Features | ✓3 features | 2 features |
| States Available | ✓50 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amble
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Arc-1
Pros
- ✓Both compounded semaglutide and tirzepatide available
- ✓Per-dose purchasing — no subscription or membership required
- ✓25% off + free shipping promotional offer
- ✓Broader longevity formulary (Rapamycin, NAD+, Sermorelin)
Cons
- ✗No visible LegitScript or PCAB accreditation
- ✗No legal entity name or address disclosed
- ✗State availability not disclosed
- ✗Pricing is per-dose not monthly — higher doses are very expensive ($1,085-$1,585 for semaglutide 1.75-2.5mg)
- ✗No named clinicians or pharmacy partners
Our Verdict
Amble edges out Arc-1 with a higher overall score of 7.4/10 and is particularly strong for mainstream telehealth GLP-1 access. Arc-1 remains a solid alternative, especially if you're looking for patients seeking per-dose compounded GLP-1 without subscriptions.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.